Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.22.2.2
Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 988 $ 876
Restricted cash and cash equivalents 195 98
Trade and other receivables, net of current expected credit losses 805 580
Accounts receivable—affiliate 447 232
Accounts receivable—related party 0 1
Advances to affiliate 150 141
Inventory 241 176
Current derivative assets 27 21
Margin deposits 59 7
Contract assets 387 0
Other current assets 74 80
Total current assets 3,373 2,212
Property, plant and equipment, net of accumulated depreciation 16,827 16,830
Operating lease assets 91 98
Debt issuance costs, net of accumulated amortization 9 12
Derivative assets 33 33
Other non-current assets, net 167 173
Total assets 20,500 19,358
Current liabilities    
Accounts payable 31 21
Accrued liabilities 1,657 1,073
Accrued liabilities—related party 8 4
Current debt, net of discount and debt issuance costs 1,498 0
Due to affiliates 56 67
Deferred revenue 162 155
Deferred revenue—affiliate 1 1
Current operating lease liabilities 9 8
Current derivative liabilities 1,157 16
Other current liabilities 4 0
Total current liabilities 4,583 1,345
Long-term debt, net of premium, discount and debt issuance costs 15,699 17,177
Operating lease liabilities 82 89
Finance lease liabilities 18 0
Derivative liabilities 3,981 11
Other non-current liabilities—affiliate 21 18
Partners’ equity (deficit)    
Common unitholders’ interest (484.0 million units issued and outstanding at both September 30, 2022 and December 31, 2021) (3,059) 1,024
General partner’s interest (2% interest with 9.9 million units issued and outstanding at September 30, 2022 and December 31, 2021) (825) (306)
Total partners’ equity (deficit) (3,884) 718
Total liabilities and partners’ equity (deficit) $ 20,500 $ 19,358